This bill, titled the Consistent Egg Labels Act of 2025, seeks to prevent consumer confusion and misrepresentation by requiring rigorous enforcement against misbranded egg alternatives. It amends the Federal Food, Drug, and Cosmetic Act to establish a clear definition for what constitutes an "egg" or "egg product" . Under this amendment, an egg is defined as the reproductive output of avian poultry species, including an albumen or yolk that was at any point encased in a calcium-based shell, while egg products must conform to existing federal regulations. The legislation prohibits any food from being introduced into interstate commerce using a market name for an egg or egg product if it does not meet these specified criteria, thereby ensuring that consumers are not misled by alternative products. The Secretary of Health and Human Services, through the Commissioner of Food and Drugs, is directed to issue draft and final guidance on enforcement within 180 days and one year, respectively, and any inconsistent prior guidance will be nullified. Furthermore, a report to Congress is required within two years to detail enforcement actions, including warnings and penalties, and to provide an updated plan if misbranded products persist in the market.
This bill, titled the Consistent Egg Labels Act of 2025, seeks to prevent consumer confusion and misrepresentation by requiring rigorous enforcement against misbranded egg alternatives. It amends the Federal Food, Drug, and Cosmetic Act to establish a clear definition for what constitutes an "egg" or "egg product" . Under this amendment, an egg is defined as the reproductive output of avian poultry species, including an albumen or yolk that was at any point encased in a calcium-based shell, while egg products must conform to existing federal regulations. The legislation prohibits any food from being introduced into interstate commerce using a market name for an egg or egg product if it does not meet these specified criteria, thereby ensuring that consumers are not misled by alternative products. The Secretary of Health and Human Services, through the Commissioner of Food and Drugs, is directed to issue draft and final guidance on enforcement within 180 days and one year, respectively, and any inconsistent prior guidance will be nullified. Furthermore, a report to Congress is required within two years to detail enforcement actions, including warnings and penalties, and to provide an updated plan if misbranded products persist in the market.